tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Yasmeen Rahimi, 405 are a BUY (98.06%), 8 are a HOLD (1.94%).
Analyst Yasmeen Rahimi, currently employed at PIPER SANDLER, carries an average stock price target met ratio of 41.58% that have a potential upside of 47.93% achieved within 246 days. Previously, Yasmeen Rahimi worked at ROTH MKM.
Yasmeen Rahimi’s has documented 778 price targets and ratings displayed on 65 stocks. The coverage is on Healthcare, Industrials, Technology, Basic Materials, Financial Services, Utilities sectors.
Most recent stock forecast was given on NKTR, Nektar Therapeutics at 08-May-2026.
Analyst best performing recommendations are on NRBO (NEUROBO PHARMACEUTICALS).
The best stock recommendation documented was for NRBO (NEUROBO PHARMACEUTICALS) at 8/9/2018. The price target of $12000 was fulfilled within 1 day with a profit of $7620 (38.84%) receiving and performance score of 388.38.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 15-Feb-2023
$42
$-2.15 (-4.87%)
$42
3 years 4 months 23 days ago
(15-Feb-2023)
0/16 (0%)
$-2.18 (-4.93%)
Hold Since 11-Jan-2023
$42
$-2.15 (-4.87%)
$68
3 years 5 months 27 days ago
(11-Jan-2023)
0/3 (0%)
$-2.1 (-4.76%)
Hold Since 11-Jan-2023
$42
$-2.15 (-4.87%)
$82
3 years 5 months 27 days ago
(11-Jan-2023)
0/4 (0%)
$-2.1 (-4.76%)
Hold Since 11-Jan-2023
$55
3 years 5 months 27 days ago
(11-Jan-2023)
0/1 (0%)
$36.77 (201.70%)
Buy Since 09-Jan-2023
$42
$-2.15 (-4.87%)
$61
3 years 5 months 29 days ago
(09-Jan-2023)
0/2 (0%)
$-1.85 (-4.22%)
Which stock is Yasmeen Rahimi is most bullish on?
Which stock is Yasmeen Rahimi is most reserved on?
What Year was the first public recommendation made by Yasmeen Rahimi?
